Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Cabaletta Bio Inc increased its cash reserves by 136.79%, or 111.63m. Cash Flow from Financing totalled 187.63m or -- of revenues. In addition the company used 53.55m for operations while cash used for investing totalled 22.45m.
Cash flow per share | -1.90 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.13 |
---|---|
Tangible book value per share | 4.13 |
More ▼
Balance sheet in USDView more
Current ratio | 11.52 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼